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Abstract 
Background: Patients can be tested for IgE sensitivities with in vivo or in vitro testing, but patients’ experiences of 
different allergy test modalities have not been studied. The objective of this study was to investigate adult patients’ 
experiences, views and preferences for allergy testing, exploring skin prick testing and allergen-specific IgE testing.
Methods: A qualitative study of adults attending out-patients for investigation of a suspected allergy. A purposive, 
convenience sample identified participants and semi-structured interviews were conducted, face to face or by tel-
ephone. Interviews were recorded and transcribed verbatim. Thematic content analysis was used to explore patients’ 
experiences.
Results: 23 patients were interviewed. The characteristics of skin prick tests particularly valued were the immediacy 
and visibility of results, which enabled testing and interpretation to be achieved within a single clinic appointment. 
In vitro testing offered patients simplicity and procedural speed, necessitating only a single puncture site, and was 
perceived to be a superior test as it was conducted in a laboratory.
Conclusions: The patient preferred method of allergy testing was skin prick testing rather than in vitro allergen spe-
cific IgE testing. However, most patients were accepting of either testing modality because their desire to confirm or 
exclude an allergic trigger overrode any perceived disadvantages of the test method.
Trial registration: Not applicable as study descriptive and qualitative.
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Background
Allergy diagnostic tests are used as adjuncts to the clini-
cal history and physical examination in formulating the 
diagnosis for the patient. Two most commonly used 
methods of confirming IgE-mediated sensitisations are 
in  vivo percutaneous skin tests (SPT) or in  vitro spe-
cific IgE testing. SPT involves placing a drop of allergen 
reagent onto the skin of the patient and using a 1  mm 
lancet to puncture the epidermis. A positive response 
is indicated by the development of a wheal and flare 
response. The serum allergen specific IgE test involves 
the standard venepuncture procedure with serum IgE 
levels being analysed by immunofluorescence-based 
immunoassay (ImmunoCAP). The SPT is the gold stand-
ard, however the serum allergen specific IgE test is used 
when patients have severe dermatographism or are una-
ble to stop taking antihistamines [1].
Whilst patient’s perceptions of pathways to and acces-
sibility of allergy testing, have been investigated in one 
previous study [2], no study has addressed patients’ 
experiences and preferences of test modality, despite a 
growing need to consider this. Currently there is a move 
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In the UK a recent NHS reform programme, ‘Creating a 
Patient Led NHS’, challenges us to move away from the 
traditional, rather paternalistic health service that ‘does 
things for its patients’ and move towards one that is 
patient led in its organisation and delivery [3]. Address-
ing patient’s experiences enables the development of 
patient-focused care which in turn improves satisfaction, 
health outcomes and the physician’s performance [4]. 
Using qualitative methods, we were able to gain insight 
into the experiences and views of adult patients under-
going allergy testing and the reasons for their expressed 
preference for in vivo skin prick testing or in vitro serum 
allergen specific IgE testing.
Methods
Due to the study’s exploratory nature of a health topic 
that has received little previous investigation a qualitative 
approach was used with one-to-one interviews.
Patient recruitment
Adult patients, 17  years old and above, were recruited 
from an Allergy outpatient clinic in a teaching hospital in 
the south east of England. Patients were eligible if they 
had undergone any allergy testing in this clinic in the 
preceding 8–10  weeks. Purposive sampling, rather than 
random sampling, was used to ensure we had informants 
from a wide age range. Interested patients were provided 
with verbal and written information about the study 
before written consent was obtained.
Interviews
In-depth interviews were conducted, face to face or by 
telephone, by three researchers (LS, CB & AR) independ-
ent of allergy service provision and trained in qualita-
tive methods. A topic guide developed, with input from 
clinical colleagues, to shape the conversation around the 
patient’s experiences of allergy testing, probing to under-
stand the expressed positive and negative experiences. If 
interviewees had experience of both in vitro and in vivo 
allergy testing they were asked to compare and con-
trast their experiences. If a participant had only under-
gone one mode of testing they were given a standardised 
description of the other test procedure and asked to 
reflect on that. This enabled all participants to comment 
on their preference for mode of allergy testing. Interviews 
were recorded and transcribed verbatim.
Data analysis
The transcripts were analysed using Burnard’s method, 
a very structured and rigorous approach for the-
matic content analysis [5]. To ensure reliability data 
were initially analysed by each researcher to inde-
pendently develop a coding framework, these were 
then compared and discussed to develop an analytical 
framework with eight themes. Results are illustrated 
with selected quotes to illustrate the theme being 
discussed; the gender and age of the respondent are 
shown in parenthesis.
Results
Twenty-three interviews were conducted. Respondents 
ranged in age from 17 to 77 years (mean 40, mode 31), 13 
(56.5 %) were females. Fourteen respondents had recently 
experienced SPT, seven patients had received both a 
SPT and specific IgE blood test and two had undergone 
the blood test only. Eight patients had experience of 
allergy testing in the past and all patients had undergone 
venepuncture before (Table 1). 
Understanding of skin prick testing procedure
Patients’ knowledge of skin prick testing prior to their 
outpatient consultation was variable, mainly uninformed, 
some admitted to having ‘never heard about it’, or if they 
had had one previously, not remembering the detail. 
Where they did recall recent information, relatives and 
friends were the main sources, and the information was 
often partial:
‘Well I’d only ever heard about the, the, when they 
put the thing on your forearm. I didn’t realise it was 
a pinprick, I though they just put a bit of solution, 
they put on there and done you that way.’ (Male, 41)
‘I knew that I was going to have little drops on my 
arms, but I didn’t know that they were going to 
scratch the surface ……’ (Female, 43)
Other patients were misinformed or had 
misconceptions:
‘I thought someone was going to scrape a bit of my 
skin off and take a bit of blood, that’s what I thought.’ 
(Male, 31)
The SPT procedure
The SPT procedure was fluently recalled:
‘Marked my arm with that strip and then put the 
drops of each thing on and then used the needle to 
prick the skin and then sat me in the waiting room. 
Waited for a while and then called me into check 
whether I had reacted to anything, which I hadn’t….’ 
(Male, 31)
The SPT procedure was described largely as accept-
able, the descriptors used ranged from ‘no problem’ or 
‘not painful’ through ‘fine’ or ‘ok’ to ‘very good’ or ‘per-
fectly comfortable’. ‘It didn’t hurt’ was a very common 
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descriptor, for example ‘you know I was a bit anxious 
about it, because I am not very good with pain generally, 
(laughs) but actually it was absolutely fine, it didn’t hurt it 
was fine.’ (Female, 43)
Two respondents mentioned the anxiety generated by 
learning their skin would be pierced, but the reality was 
not problematic, ‘…it just felt like getting a pine needle.’ 
(Female, 22)
However, there were some who described their SPT in 
more negative terms:
‘it was like I’d been bitten by a million ants or some-
thing, it was pretty intense, having 10 needles all at 
once, but it wasn’t unbearable, it was you know, I 
knew it was going to happen.’ (Female, 32)
‘well I think that was the most, the most discomfort 
I’ve had, being in the allergy clinic, that part, it, I 
thought I didn’t like it at all.’ (Male, 41)
One person described his concern that not all the pin 
pricks were equal:
Table 1 Demographic and clinical characteristics of adult participants
ID Age Sex Patient preference SPT 
versus blood test
Occupation Presenting problems Previous allergy test-
ing? (details, if known)
Recent allergy testing
A1 17 M SPT Student Rhino-conjunctivitis Yes (SPT) Blood test
A2 27 F No preference Credit control analyst Suspected sea food 
allergy
Yes (SPT) SPT
A3 31 M SPT Project manager Seasonal rhinitis Food 
allergies (egg and nuts)
Yes (SPT & Blood test) SPT & Blood test
A4 23 F Blood test Secretary Venom anaphylaxis No Blood test
A5 31 M Blood test Financial advisor Churg-Strauss syndrome 
–rhinitis, polyps
No SPT
A6 57 M SPT Director of engineering 
company
Angioedema No SPT & Blood test
A7 31 M SPT Manual labourer Perennial rhino-conjunc-
tivitis
No SPT
A8 31 M SPT Barber Perennial and seasonal 
rhino-conjunctivitis
Yes (SPT) SPT & Blood test
A9 77 F SPT Retired Suspected latex allergy No SPT
A10 32 F SPT Accounts manager Seasonal Rhinitis Oral 
allergy syndrome
No SPT
A11 40 F SPT Freelance journalist Seasonal and perennial 
rhinitis
No SPT
A12 75 F SPT Retired Suspected food allergy Yes (Blood test) SPT
A13 43 F SPT Graphic designer Seasonal and perennial 
rhinitis
No SPT
A14 48 F SPT Children’s social worker Seasonal rhino-conjunc-
tivitis
No SPT
A15 44 F Blood test Nurse Perennial rhinitis No SPT
A16 60 F SPT Nurse Angioedema Yes (SPT & Blood test) SPT
A17 22 F SPT Student Asthma triggered by cat 
exposure
No SPT
A18 42 F SPT Media/PR agency (3) Asthma and rhinitis 
Suspected sea food 
allergy
No SPT & Blood test
A19 28 M SPT Chef Seasonal rhinitis Oral 
allergy syndrome
Yes (SPT) SPT
A20 31 M SPT Political campaign officer Perennial rhino-conjunc-
tivitis
No SPT
A21 23 M SPT Retailer Difficult to control 
asthma
No SPT and Blood test
A22 41 M Blood test Painter and decorator Asthma, suspected dog 
allergy
No SPT & Blood test
A23 58 F No preference Voluntary financial work Anaphylaxis, suspected 
nut allergy
Yes (SPT) SPT & Blood test
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‘I was a bit concerned sometimes when the skin was 
being pricked. I was a bit concerned as to whether 
some of those things that you use to prick were pricky 
enough. I felt some of them and I didn’t feel some of 
the other ones. So some were actually I could feel 
them pricking me where others I didn’t feel prick 
me and I almost thought that it wasn’t done hard 
enough, if that makes sense?
So my trust in the process was a little bit wary.’ 
(Male, 31)
He was therefore worried that there would be poten-
tially false negative results where there was no sensation 
of the lancet piercing his skin. As it happened, some of 
those tests where he was not sure the lancet had pierced 
the skin enough did react, so he was reassured. However 
had his results been negative he may not have been con-
vinced of the accuracy of the results.
Longer term discomfort
In their accounts of their experiences of skin prick testing 
respondents distinguished between the sensations of skin 
pricking and the subsequent discomfort whilst waiting 
for the results to be read: 
‘You know it’s not really nice feeling, its irritation 
obviously.’ (Male, 28)
‘It, it was fine. I mean it was really itchy afterwards, 
but the actual test was fine’ (Male, 23)
Only one person described prolonged discomfort, say-
ing ‘that skin prick test one, it made my arm itch for days 
after’ (Male, 41)
Interpretation of SPT
Several aspects about the experience of acquiring the 
SPT results were commented on, including speed, visibil-
ity and impact. The rapid availability of the SPT results 
was greatly valued, respondents described the results as 
being ‘instantaneous’, ‘in real time’ or ‘immediate’, ‘You 
know within 15 min you’ve got the results.’ (Male, 31)
Another positive aspect was the visibility of the emerg-
ing response and comparing the size of the different reac-
tions, ‘We sat there all waiting to see if we reacted to it 
….you can physically see as a patient.’ (Male, 31). This vis-
ibility was described with adjectives such as ‘interesting’ 
and ‘informative’, but also as ‘empowering’ and ‘engaging’.
‘I liked the fact that you could see what you reacted to 
so it was very obvious that you had a reaction to them 
rather than someone just telling you, you are allergic to 
something’. (Male, 31)
Not being entirely dependent on a third-party and being able 
to ‘confirm that for my own eyes’ was perceived as a powerful 
aide to patient understanding and as a prompt to action:
‘That was quite a good way of illustrating the allergy.’ 
(Male, 31)
‘I reacted quite badly to the dust….blatantly obvious 
how bad it was, and it prompted us to rip up our 
carpets for example, and get laminate flooring so it 
doesn’t hold the dust in the room, and that kind of 
thing.’ (Male, 23)
Opportunity to discuss test results
Clinician interpretation of the results 15 min later gen-
erated a valued opportunity to discuss the implications 
of the findings within the same outpatient visit rather 
than having to wait to be informed by post or return for 
a follow up appointment. Despite these face-to-face dis-
cussions some misunderstandings were highlighted, for 
example one patient recalled the explanation of his Pollen 
Food Syndrome as contamination with pollen rather than 
cross- reaction with other food proteins:
‘….I’m increasingly reacting to fruits and hazelnuts, 
um skin tests didn’t detect that I was allergic to the, 
um because I’m allergic to pollen the suggestions was 
that the pollen gets into the fruit and the hazelnuts 
and that could cause me to react, so um that’s kind 
of useful information.’ (Male, 31)
The interpretation of a wheal as sensitisation not 
allergy was also confusing to some. One patient asked:
‘Does that mean I am a little bit allergic to salmon, 
to cod, to the, to the, to the, but I mean I eat that on 
a daily basis.’ (Female, 27)
In vitro testing experiences
Blood taking process
When talking about their experiences of in vitro allergy 
testing respondents focussed on the venepuncture pro-
cedure and there was limited awareness of what the test 
was assessing or what happened to the sample in the lab-
oratory. Patients referred to it generically as ‘a blood test’ 
and commented on comfort and speed, for example
‘It was fairly good, fairly fast and it didn’t hurt or 
anything.’ (Male, 17)
‘It didn’t take longer than 2  min.’ (Male, 31)Some 
respondents described a degree of physical pain, ‘not too 
bad’, ‘just mild discomfort’. Discussing their venepuncture 
for in  vitro allergy testing prompted memories of pre-
vious blood sampling, respondents often digressing to 
recall less than optimal experiences of locating a vein or 
the resultant bruising. Some respondents described their 
coping strategies for venepuncture ‘I look away and don’t 
watch the needle go in’ (Male, 31). Others alluded to 
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emotional rather than physical discomfort, ‘No forewarn-
ing, I was wearing a top that I had to take off’ in an area 
she perceived as communal. (Female, 58)
Delay receiving blood test results
Whilst the speed of venepuncture was noted respondents 
also talked less favourably about the time to obtaining results
…it doesn’t take much time, but with the blood test it 
take a few weeks to get the results back.’ This respondent 
went on to comment on the impact of the results ‘….and 
you don’t see it for yourself so you’re obviously relying on 
someone else to you know, make the judgement about 
whether you reacted to it. …. there’s still that slight doubt 
in my mind that I may react to them…. Information can 
get lost in translation.’ (Male, 31)
However, this delay was not always perceived as neg-
ative, one lady described how it gave her time to accli-
matise ‘…it was all quite new and frightening so I wasn’t 
really in a hurry [to know]….’ (Female, 23).
People had different experiences of learning of their IgE 
results, some in person, some written ‘letter in the post…
with a paragraph about the blood test’ and some were 
still waiting.
Perceived strengths of the different test modalities
Characteristics frequently listed in favour of SPT 
included minimal discomfort, immediacy of the results 
and the opportunity to see the results oneself (‘it really 
did flare up….quite substantially. Whereas ……. a blood 
test, you don’t see it’ (Male, 17)) and to discuss the 
results. The attributes of IgE in comparison to SPT were 
single puncture site (‘I think a blood test would be bet-
ter. Because it’s just a prick.’ (Female, 44)) and minimal 
patient involvement.
Respondents also talked about their perceptions of 
blood testing as being more technical and having greater 
discerning powers:
‘I mean the prick test, as I said, it’s a very simple one, 
and the blood test is probably a more in depth test.’ 
(Female, 27)
‘I think that a blood test is more accurate because 
it’s kind of part of you, more than just a few dots on 
a skin prick test. I think it can find out really what is 
wrong with you.’ (Female, 23)
This perception of superiority of in  vitro testing was 
sufficient for some interviewees to reflect on their will-
ingness to tolerate pain or overcome needle phobia for a 
better test:
‘I mean I hate blood tests, but if having a blood tests 
means that I would know what definite, you know I am 
allergic to then I will do it.’ (Female, 27)
Three respondents (two nurses and one financial 
adviser) spontaneously brought up issues relating to 
the efficiency of the two testing modalities, making a 
comparison between ‘one injection’ and the very visible 
multi-stage process of SPT with lancet pricks, waiting, 
and clinical interpretation and feedback. They wondered 
whether venepuncture was ‘more efficient from the NHS’ 
point of view’. One respondent commented:
‘…. [in vitro testing] may be cost saving, to give a vial 
of blood that goes off, to haematology or whichever 
department will look at it, and they’ll go do their 
tests. And so you haven’t got loads of people run-
ning round measuring things, pricking arms, sending 
you back into the waiting room, sending you back in 
again.’ (Female, 60)
Qualitative research does not generally seek to enu-
merate, but at the close of the interview respondents 
were asked to comment on their preference for allergy 
test modality. Some patients were very decisive; others 
hesitated before coming to a conclusion, explaining that 
their desire to confirm or exclude an allergic trigger may 
override any perceived disadvantage of the allergy test.
‘So I wouldn’t mind either of them to be honest. As 
long as it does, you know it does tell me what is my 
problem.’ (Female, 27)
Seventeen of the 23 patients finally expressed a prefer-
ence for SPT and four for in  vitro testing. The remain-
ing two had ‘no strong feelings either way’ and perceived 
the two testing modalities as equivalent. Of the ten par-
ticipants who had experience of both in vivo and in vitro 
allergy testing, eight expressed a preference for skin prick 
testing, one for venepuncture and one expressed no pref-
erence. This distribution of expressed preferences was 
mirrored in those who had only theoretical knowledge of 
one or other of the allergy testing modalities.
Discussion
Exploring patients’ experiences and preferences for 
allergy testing in open ended interviews demonstrated 
many positive views about SPT, its valued attributes 
including the immediacy of the results and the oppor-
tunity to see the results for one’s self. From the inter-
viewees’ perspective in  vitro testing offered speed and 
simplicity of patient involvement, single puncture site, 
and no residual side effects, such as itching. SPT was the 
preferred method of allergy testing for the majority of 
patients. Without any understanding of what happened 
to the blood sample once taken, in vitro testing was per-
ceived as technically superior and it was this assumption 
that sometimes led to patients’ ambivalence of testing 
modality or an expressed preference for a blood test.
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Strengths and weaknesses
There are studies comparing the performance char-
acteristics of in  vitro and in  vivo tests (sensitivity and 
specificity), but this is the first in-depth qualitative study 
investigating patients’ experiences, and views of allergy 
testing. The semi-structured interviews enabled partici-
pants to raise issues important to them and produced 
rich information covering many aspects of the allergy 
testing process in an outpatient setting. We took steps 
to increase the validity of our data, including the use of 
interviewers with no clinical expertise in allergy in order 
to reduce the possibility of contamination of lay beliefs 
with professional views and knowledge. A systematic and 
fully documented approach to data analysis was under-
taken by three researchers independently to minimise 
researcher bias. Our purposive sampling achieved a sam-
ple with a range of ages, socioeconomic backgrounds 
and clinical conditions in which we could explore simi-
larities and differences in views. With its narrow aim, 
high specificity (participants had all recently undergone 
allergy testing) and the focused dialogue this study would 
be categorised as a qualitative study with high informa-
tion power [6]. Validity was further ensured by continu-
ing sampling until data saturation was achieved, that is 
the point at which three consecutive interviews did not 
reveal any further themes. Recruiting patients from a 
single institution could be considered a weakness of the 
study, but interviewees drew on their experiences of 
allergy care from other health care settings, together with 
experience of venepuncture for other medical problems. 
As the data were collected in the context of the British 
National Health Service where care is free at the point of 
delivery, some caution may be required in generalising 
our observations on preference to systems where patients 
pay for their healthcare and where differential personal 
costs may influence choice. The data about the actual 
allergy testing experience is more generalizable, but inev-
itably there are context specific factors which influence 
responses, for example in our hospital it is the physician 
who performs and reads the SPT, but a phlebotomist 
takes the blood samples.
Implications for clinical practice
Patients’ perspective reflects the anecdotal professional 
perspective ranking percutaneous testing first, but their 
reasons are different. Clinicians see the advantages of 
SPT as being minimally invasive, having good reproduc-
ibility, being easily quantified, and allowing the evalua-
tion of multiple allergens at one session. From a clinical 
perspective in vitro tests are used when in vivo testing is 
contraindicated, as in patients with extensive dermatoses 
(e.g. atopic dermatitis or dermatographism) or patients 
unable to discontinue their antihistamines. We asked 
respondents to express their preferences but we recog-
nise that there may not always be a patient choice (for 
example, a patient needing testing for venom allergy or 
component based diagnosis in the assessment of cross-
reactivity or the prediction of severe, persistent symp-
toms), or  when one test method is inappropriate or 
contraindicated. In some situations choice may be lim-
ited by availability or resource, for example where allergy 
testing is used so infrequently that having a range of aller-
gens with limited shelf lives is not justifiable. Interest-
ingly patients were sometimes bemused with the concept 
of choice in health care and verbalising their preferences, 
‘It’s one of those things, you got to have it done, and you 
know you just accept that that’s the method to find out 
what you are allergic.’
An unintended benefit of this study was thorough feed-
back on our allergy service; patients commented that 
they did not always get a copy of their SPT results; the 
disruption of moving between different clinical areas 
for consultation, SPT and waiting; interruptions of their 
clinician by other staff. Our study also highlighted some 
weaknesses of patient–practice communication, for 
example when the allergen raised a wheal, but not one of 
sufficient size to be interpreted as a positive test result. 
Such patient misunderstanding of test positivity could 
have significant long term implications for their diet, 
activities and quality of life.
Comparison with other studies
There has been much research into patient perceptions 
of the generic process of venepuncture, but no study has 
focussed on serum allergen specific IgE testing. Com-
pared to SPT our participants had relatively little to say 
about in vitro testing. Interestingly this reticence to talk 
about venepuncture has been observed in another study 
exploring what people know and think about venepunc-
ture and blood. Pfeffer et  al. [7] found that their par-
ticipants had very little to say about blood tests because 
venepuncture is widely understood as something ‘they 
just do in hospitals’. It is accepted without questioning, 
and is not perceived as worthy of discussion as it is eve-
ryday practice, and one which patients submit to by com-
mon consent, as de Certau describes, it is the ‘law of the 
place’ [8].
New skin prick testing devices are being developed with 
recent growth in multi-headed devices which allow for 
the application of several antigens simultaneously. New 
devices have been subject to head-to-head comparisons 
with existing devices for intra-device variability (wheal 
and flare sizes, sensitivity and specificity). Advertising of 
diagnostic devices focus on physician preferences and the 
patient’s perspective is rarely addressed, but one study 
comparing eight commonly used skin test devices (four 
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multi-headed and four single devices) measured patient 
discomfort using the Wong-Baker FACES pain rating 
scale [9]. Pain was assessed only within seconds of the 
application of the skin test to minimise the influence of 
histamine on pain perception. The mean pain score for 
all devices tested ranged from 0.88 to 2.04 out of 10. 
These scores are considered to represent mild pain and 
our qualitative data are consistent with these quantitative 
observations.
Conclusions
Diagnostic testing and allergen recognition is an essential 
part of the evaluation of a patient with suspected allergy. 
This naturalistic study provides insight into patients’ 
experiences and views of allergy testing. Many patients 
expressed a preference for skin prick testing, but this 
preference was not universal.
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